Over the past couple of years, cannabis has become a major topic in many countries’ agendas due to its therapeutic benefits. Regulators worldwide are now exploring opportunities within the cannabis market as it can be used as an alternative to certain traditional medical treatments. In particular, the U.S. marketplace is expected to be one of the most explosive markets. Despite cannabis still being federally illegal within the U.S., certain states, such as California and Colorado, which have legalized recreational cannabis contribute billions of dollars in revenue annually. Moreover, cannabidiol or CBD-based products have become increasingly common across the U.S. In late 2018, U.S. President Donald Trump signed the U.S. Farm Bill into effect, allowing the production of hemp. Shortly after, convenience stores and pharmacies began carrying hemp-derived CBD products. Even major pharmaceutical chains have begun to carry CBD products, promoting their healthcare benefits such as treating medical conditions and pain relieving properties. The U.S. Food and Drug Administration also approved the first cannabis-derived drug, Epidiolex, which is already being used to treat epilepsy in children. Overall, the combination of all of these recent events has exponentially accelerated the CBD marketplace. Moving forward, the CBD market is expected to continually grow as more countries began to adopt cannabis legalizations. According to data compiled by Brightfield Group, the U.S. CBD market is expected to reach USD 22 Billion by 2022. SinglePoint Inc. (OTC: SING), PotNetwork Holdings, Inc. (OTC: POTN), MassRoots, Inc. (OTC: MSRT) mCig, Inc. (OTC: MCIG), Medical Marijuana, Inc. (OTC: MJNA)
CBD is primarily being advertised as a medical supplement, however, some companies have taken the opportunity to integrate CBD into other products. Consumers can now find CBD in products such as beauty products, beverages, and even pet treats. Consumers can also take CBD purely for recreational purposes, to relax, as well as use it for medical applications. The wide range use of CBD creates a versatile market and expands outwards to many consumers. “A few years ago almost no one knew what hemp-derived CBD was, it was sold by mostly small brands of tinctures online and through head shops. All of a sudden, CBD is everywhere – it is both a trendy, new ingredient in drinks, face creams and pet treats and an answer to the prayers of so many people suffering from medical conditions ranging from epilepsy to anxiety and chronic pain. It rides the waves of so many global food and health trends, as a substitute for opioids, towards more natural health alternatives and functional ingredients,” said Bethany Gomez, Managing Director at Brightfield Group.
SinglePoint Inc. (OTCQB: SING) today announced, “the filing with the SEC of the Company’s first annual report as a fully reporting issuer. SinglePoint ended 2018 with total sales of $1,154,671 an increase of 344% compared to the previous year. The increase is largely due to the success of SinglePoint executing on its acquisition strategy. Over the last year the Company has solidified its’ financial position as well as become a fully reporting, audited issuer.
SinglePoint plans to continue its momentous growth with its latest Asset Purchase Agreement with Direct Solar. Direct Solar has seen tremendous growth over the past few months. SinglePoints’ auditing firm is currently reviewing the financial statements and upon completion will finalize the acquisition.
“We have spent a lot of time and effort to put the Company in a position to turn a profit in the very near future. With the anticipated acquisition of Direct Solar and the explosive growth we are seeing that goal could become a reality. We are excited about the future of SinglePoint and are in a stronger position now than we have ever been,” states Greg Lambrecht CEO.
About SinglePoint Inc: SinglePoint Inc (SING) is a technology and investment company with a focus on acquiring companies that will benefit from the injection of growth capital and technology integration. The Company portfolio includes mobile payments, ancillary cannabis services and renewable energy solutions. Through acquisitions into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued companies, thereby providing a rich, diversified holding base.”
PotNetwork Holdings, Inc. (OTC: POTN) is a publicly traded company that acts as a holding company for its principal subsidiaries, First Capital Venture Co., the owner of Diamond CBD, Inc., the maker of Diamond CBD products. Diamond CBD Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. recently announced that it is presenting its popular line of Diamond CBD oils, edibles, and creams to several large pharmacy chains. Recently passed federal legislation that legalizes industrial hemp production in the United States has generated increased mainstream acceptance of CBD-based products and drawn interest from retailers looking to capitalize on the public’s desire for products that reduce stress and anxiety. “Our array of CBD products already play an active role in the wellness routine of thousands of Americans,” said Kevin Hagen, Chief Executive Officer of Diamond CBD parent company PotNetwork Holdings, Inc. “That’s why we are happy to present the benefits of CBD and our popular oils, edibles and beauty products to several large pharmacy chains in the days ahead.”
MassRoots, Inc. (OTCQB: MSRT) is a leading technology platform for the regulated cannabis industry. Marijuana Company of America recently announced that the Company’s wholly-owned subsidiary hempSMART has entered into a strategic marketing agreement with MassRoots, Inc. to promote its hemp CBD formulated product line. Under the terms of the agreement, MassRoots agreed to participate as an associate in the Company’s associate marketing platform, to help promote and sell hempSMART products on www.massroots.com, as well as MassRoots’ app and other social media outlets. “We’re excited to begin educating MassRoots’ community of over a million cannabis consumers about hempSMART’s innovative line of CBD products,” stated MassRoots’ Chief Executive Officer Isaac Dietrich. “We look forward to driving our audience to a company that focuses on providing consumers with the highest-quality of ingredients and products, which is ultimately why we’re partnering with MCOA.”
mCig, Inc. (OTCQB: MCIG), headquartered in Jacksonville, Florida, is a diversified company servicing the legal cannabis, hemp and CBD markets via its lifestyle brands. mCig, Inc. recently announced that its wholly-owned subsidiary, CBJ Distributing, is expanding its sales reach by introducing to its clients in Nevada and California a new in-house developed product line of hemp pre-rolled cigarettes and CBD vape pens with a proprietary terpene rich formula. CBJ Distributing saw its sales increase dramatically during the last year. The company distributes its line of cannabis supply items, such as: labels, jars, childproof envelopes, vape pens, to almost all dispensaries in Nevada, while enlarging its market share in southern and central California. After carefully analyzing the CBD market, CBJ Distributing decided to expand its product line by joining this huge opportunity of selling hemp products to smoke shops and dispensaries around the Country. “We have a strong team of professionals with boots to the ground, following the trends, growth, and needs of the market through client-based communication and customer service. Since its acquisition in May 2018, CBJ Distributing has consistently been the strongest division of MCIG, with a constant and continued growth in sales and profits. Our management team at CBJ Distributing gets results!” said Paul Rosenberg, Chief Executive Officer of MCIG. Mr. Rosenberg went on to say, “During the past month, the MCIG officers and Board of Directors have had multiple meetings in our Las Vegas office with the CBJ management team where we have identified the direction MCIG must take in order to be a top cannabis company going forward.”
Medical Marijuana, Inc. (OTC: MJNA) mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. Medical Marijuana, Inc. recently announced that its subsidiaries Kannaway®, HempMeds® and Dixie Botanicals all received Certification Seals from the U.S. Hemp Authority. To receive this seal, companies must have met several stringent industry standards laid out for quality and safety. The certification is intended to educate hemp farmers and producers about Food and Drug Administration Current Good Manufacturing Practices (cGMP) and Good Agricultural Practices (GAP) to guarantee that consistent quality is achieved. The U.S. Hemp Authority Certification Program is administered by experienced quality assurance and verification professionals from industry-leading food and agricultural companies. “We are honored to have received these Certification Seals for several of our subsidiaries,” said Medical Marijuana, Inc. Chief Executive Officer Dr. Stuart Titus. “Our customers’ safety is our priority and we are proud to have our high-quality manufacturing processes confirmed so that consumers understand that buying from us means that they have access to safe and accurately labeled hemp-derived products, including fiber, seed and extracts, such as cannabidiol (CBD).”
Subscribe Now! Watch us report LIVE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
Experienced Industry Veteran Tony Mingo Joins O’Neil Digital Solutions
O’Neil Digital Solutions (ODS), a leader in data-driven publishing and plan sponsor/participant communication services, recently announced that long-time financial technology (fintech) veteran Tony Mingo has joined the organization as its Managing Director, Professional Services in the financial vertical.
Mingo’s role is “to assist cutting-edge companies in their data-transformation strategies.”
Before joining ODS, Mingo founded vWise, Inc., a retirement plan participant digital thought-leader, in 2006, with a vision of creating interactive solutions that engage employees with their benefits. His experience as a leader in the financial services industry spans over 28 years, with additional experience in executive management leadership within the technology industry in Silicon Valley.
“With Tony’s experience and relationships in the financial industry, we are excited to have him build and lead our Professional Service in the Financial division at ODS,” said Terry Chan, President and COO of ODS.
Mingo will focus on growing the software and professional services offerings for the firm’s financial and insurance lines of business.
“It’s about delivering a proven digital transformation strategy, from traditional output to Omni-channel conversion, as well as process improvement, change management, and SAAS platforms that serve six different verticals (retirement, banking, brokerage, property/casualty, wealth management and life insurance/annuity),” Mingo said. “It has never been more imperative that organizations provide world-class customer experiences to plan participants to strengthen their reputations and brand loyalty. Meeting these expectations requires a deeper understanding of an individual customer’s needs across the entire customer journey.”
In early 2019, O’Neil launched its Plan Health Dashboard. The Plan Health Dashboard uses a client’s plan analytics to assign a plan health score based on underlying metrics such as participation rates, income replacement ratios, and asset diversification. The metrics can be weighted to define the scoring methodology.
ODS’ Omni-channel solution, called ONEsuite, provides clients with a flexible platform to create, manage and deliver highly-personalized marketing, sales and business documents in any media and format requested by an audience.
SOURCE O’Neil Digital Solutions
Konnect -Volkswagen Group Innovation Hub TLV, Chose Seebo as the Winner of Its Startups Challenge
Seebo, a pioneer in process-based Artificial Intelligence, announced today it has won the Konnect- VW Group Innovation hub TLV Startups Challenge. Seebo was chosen following a tough judging process, by a jury of experts from the Volkswagen Group leading car brands such as Volkswagen, Audi, SEAT, Skoda, Porsche, VW Commercial Vehicles and more.
“The goal of the challenge was to find technologies that present clear business potential, cost reduction, and address real challenges.” Says Stephanie Vox, Managing Director, Konnect. “Seebo’s solution is market-ready and can rapidly impact production efficiency and costs. It was chosen based on the Volkswagen Group high standards and commitment to deliver to our customers top quality cars today and in the future.”
Seebo was selected out of dozens of start-ups that participated in the challenge. The prize recognizes Seebo’s ground-breaking technology and ensures a deep collaboration with the VW Group, for which a sum of up to 25K Euros is granted.
“We are honored to have been chosen as winners of the Smart Startups Challenge for 2019, by the leading VW Group brands, which are known for quality and innovation.” Says Lior Akavia, Seebo co-founder and CEO. “We look forward to this collaboration and to being part of the VW Group on-going pursuit for improvement in production efficiency and excellence.”
Seebo enables automotive manufacturers to reduce processes-driven quality losses and failures in production and assembly processes. Collecting and analyzing data from production lines and automated inspection systems, Seebo leverages predictive analytics and automated root-cause analysis, to ensure production efficiency is kept at its highest level.
Innovative Healthcare Startup Kermit Leverages Mendix-built Analytics Platform to Expand Services Nationwide
Mendix, a Siemens business and the global leader in low-code and no-code application development for the enterprise, today announced that Kermit, the first spend-management platform for hospitals in the area of implantable medical devices, is announcing plans to expand their services nationwide. Kermit’s innovative analytics platform, enabling hospitals to track and manage contracts, billings, and vendor compliance, was built with a single Mendix developer in less than a year. Today’s announcement underscores the fact that low code technology from Mendix is ripe for implementation within the healthcare industry.
As knee, hip, and cardio implants move from package to patient, the Mendix-built platform captures data and provides end-to-end visibility into a supplier category known for its notoriously opaque pricing and batch invoicing. With Kermit, the accurate cost and use of each medical device is captured on handheld devices as the medical item moves from point-of-service in the operating room, accurate patient billing and vendor invoice payment, and finally aggregated for contract negotiations by healthcare executives. The data-driven analytics platform transforms a hospital’s previously siloed, paper- and spreadsheet-based data collection system into a cost-savings tool that flags supplier trends, optimizes workflows and spending, and provides quick dashboard reporting that has been proven to save hospitals millions of dollars.
“We are thrilled to announce our plans to expand the Kermit services nationwide,” says Richard Palarea, CEO and co-founder of Kermit, whose company now manages 40% of the total implant spend transacting in Maryland. “Our goal is not only to provide better data and save money for resource-strapped hospitals. We also want to shine a light on fraud and abuse within the medical device marketing industry and align value and spend management initiatives for the people that dedicate their lives to saving others. Our customers are now seeing significant savings in their medical device spending category. We wouldn’t have been able to achieve all this had it not been for Mendix. We built our platform using Mendix, and I attribute a large portion of our success to the ease of using Mendix’s low-code platform.”
Providing transparency and control
Fraud and abuse often run rampant in the sales and marketing of drugs and medical devices and is difficult to track across the healthcare industry’s siloed or proprietary data warehouse systems. Kermit provides a transparent analytics platform for surgeons, supply chain managers, and healthcare executives that connects medical device data to robust visualization and analysis, empowering the full team to make quality decisions on behalf of the patient. For surgeons, the platform provides an easy and transparent way to review the costs of implantable medical devices while discussing options with patients. Kermit also ensures fair and accurate billing by keeping cases, contracts, and devices updated and organized for supply chain managers. Additionally, Kermit pulls in external business intelligence such as supplier spending trends, contract compliance, and FDA recalls of medical devices. Such items, flagged for healthcare executives and procurement managers, provide knowledge and insight on device-related inefficiencies, equipping hospital to better navigate the ever-changing reimbursement environment.
Saving hospitals millions
Hospitals are working under immense pressure to manage costs and increase savings, with many operating on profit margins of 3 percent or less. Kermit’s founding principle is to return the balance of power back to the hospital by exposing ways to eliminate millions of dollars per year in the category of medical device spending and improving patient care. The University of Maryland Medical System, which has used the Kermit analytics platform over the course of two years, has achieved upwards of $30 million in savings, with greater visibility to vendor activity and collaboration between supply chain and surgeons. Hospitals in the mid-Atlantic region that have adopted Kermit report saving 30% on average of their total implant spend per year.
Built in nine months
Palarea cites Mendix’s flexible approach to rapid application development as a key competitive differentiator. “Without Mendix, it would have taken us nearly twice as long to develop our product and required us to hire five to ten developers instead of one,” he says. “We would have lost the window of being first to market this innovative approach.”
Mendix’s cloud-native capability enables Kermit to bypass hospital firewalls for additional time and efficiency gains. “Hospital IT departments can be bottlenecks,” Palarea admits. “Enterprise solutions can take between one to three years to implement. However, our customers access our Mendix-built platform via web browsers and connectivity. This lets Kermit bypass IT involvement and deploy our solution in less than seven days.”
The healthcare industry’s digital transformation depends on healthy data. “To leverage the inherent promise of big data analytics in the healthcare supply chain of medical devices is only achieved with a deep understanding of what customers and end users truly need and use on a daily basis,” says Jon Scolamiero, Mendix manager, architecture and governance. “Mendix’s application development tools are designed to foster collaboration between business experts and professional developers. Working together, they can build and deploy responsive, mission-critical applications that quickly make an impact.”
Palarea agrees. “Mendix has allowed us to be extremely nimble and flexible,” he says. “We are literally innovating in the midst of our hospital customers who are unaccustomed to seeing value delivered so rapidly and well below the expected budget numbers.”
Latest News6 months ago
Bleckwen Raises $10m and Appoints David Christie as CEO
Artificial Intelligence6 months ago
LogRhythm Scores the Singapore Business Review Technology Excellence Award 2019 for Cyber Security – Computer Software
Artificial Intelligence7 months ago
Kneron Debuts Edge AI Chip, Bringing AI to Devices Everywhere
Artificial Intelligence2 months ago
Mogo announces a digital lending pilot with goeasy Ltd.
Artificial Intelligence8 months ago
CredoLab extends smartphone-based scoring to insurers
Artificial Intelligence2 months ago
Latest News3 months ago
OnDeck CEO Noah Breslow to Deliver Keynote Address at 2019 LEND360 Conference
Artificial Intelligence8 months ago
Chartis Research Names FICO a Category Leader in AI for Financial Services